|
Category:
Description:
Indications:
-
Postpartum,
postabortal hemorrhage due to uterine atony
-
Subinvolution,
routine management after delivery of the placenta
Contraindications:
Precautions:
-
Pregnancy
Category C; small quantities appear in breast milk
-
Rapid
IV INF (may induce sudden hypertension and CVA’s)
-
Sepsis,
obliterative vascular disease, hepatic/renal involvement
Adverse
Reactions (Side Effects):
-
CNS:
dizziness, hallucinations, headache, paresthesias, seizure
-
CV:
hypertension, palpitations, temporary chest pain, thrombophlebitis
-
GI:
diarrhea, foul taste, nausea, vomiting
-
MISC:
leg cramps, dyspnea, diaphoresis
|
Dosage:
Administered
orally, intramuscularly and intravenously
-
Adult:
-
IM/IV
0.2mg after delivery of the placenta, after delivery of the
anterior shoulder, or during the puerperium; repeat every 2-4
hours as needed
-
PO
0.2mg 3-4 times daily in the puerperium for a max of 1 week
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks. Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
|
